Marketscreener, stock market website
b4.QZkNKSqpHeuZz7alAfOMMfrRzW9OF1cKvJAm1I6swso.K897dmPMVIbIvvHLOZz5d8qeuV4qL2NG8_wVl6P_tfMJzEltW-1QmK2-7w

Log In

Forgot your password ?
Or log in with
GoogleGoogle

Email Registration
Or log in with
GoogleGoogle
Log In

Forgot your password ?
Not a member ?
Email Registration
Or log in with
GoogleGoogle
  • Markets
    Equities
    Top Capitalization
    Canada
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company calendar
    Equities Analysis
    Most popular
    CITIZENS FINANCIAL GROUP, INC.
    AMAZON.COM, INC.
    JPMORGAN CHASE & CO.
    JOHNSON & JOHNSON
    CAPGEMINI SE
    ADIDAS AG
    GE AEROSPACE
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indexes News
    TSX COMP
    TSX VENTURE
    S&P 500
    DOW JONES
    NASDAQ 100
    FTSE 100
    CAC 40
    DAX
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    CAD / USD
    CAD / MXN
    CAD / BRL
    CAD / EUR
    CAD / INR
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Nations
    Emerging Countries
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    Macroeconomics
    Policy
    Geopolitics
    Technology
    International Trade
    Military conflicts
    Taxation
    Sustainable development
    Legal, Regulation, and Crime
    Companies
    Financial Results
    Analyst Recommendations
    Transcripts
    Press releases
    Insider transaction
    Controversies
    Innovations and expansions
    IPOs
    Rumors
    Activism
    Negative surprises
    Positive surprises
    New Contracts
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Economy
    Sectors
    All our articles
    Most Read News
    Hot News
  • Analysis
    All Articles
    Must Read
    Equities Analysis
    Interviews
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
    Stock Trading Strategies
  • Calendar
    Economic Calendar
    Company calendar
  • Stock Picks
    All our investments
    United States
    Europe
    Asia, Pacific
  • Portfolios
    USA Portfolio
    European Portfolio
    Asian Portfolio
    Virtual Portfolios
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Low volatility
    Top ROE
    Yield stocks
    Trend-Following Stocks
    Multibaggers
    Growth stocks
    Investment Themes
    Homepage
    Place your bets
    Semiconductors
    3D Printing
    The Golden Age of Video Games
    Pricing Power
    uranium
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual volumes
    New Historical Highs
    New Historical Lows
    Top Fundamentals
    Fundamental Composite
    Sales growth
    Earnings Growth
    Profitability
    Finances
    Rankings Valuation
    Valuation Composite
    Capitalization
    P/E ratio
    Enterprise value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus composite
    Analyst Opinion
    Target price
    Opinion Divergences
    Estimates Revisions
    Analyst coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
  • Screeners
    Stock Screener Home
    Investment Themes
    Private Equity
    Water
    Hydrogen
    Cybersecurity
    Diabetes
    Biomass
    Technical Rankings
    Oversold stocks
    Overbought stocks
    Close to resistance
    Close to support
    Accumulation Phases
    Most volatile stocks
    Fundamental Rankings
    Top Investor Rating
    Top Trading Rating
    Top Consensus
    Top Growth
    Top Dividends
    Low valuations
    My Screeners
    All my stocks
    Watchlists
    Virtual Portfolios
  • Tools
    MarketScreener tools
    Stock Screener
    iPhone app
    Expert tools
    Stock Screener PRO
    Portfolio Creator
    Event Screener
    Dynamic Chart
    Company calendar
    Economic Calendar
    Currency Converter
  • Our Services
    Our subscriptions
    Our Stock Picks
    Stock Screener
    Thematic Investment Lists
    MarketScreener Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
  • Homepage
  • Markets
    • Equities
      • Top Capitalization
      • Canada
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company calendar
      • Equities Analysis
      • Most popular
      • CITIZENS FINANCIAL GROUP, INC.
      • AMAZON.COM, INC.
      • JPMORGAN CHASE & CO.
      • JOHNSON & JOHNSON
      • CAPGEMINI SE
      • ADIDAS AG
      • GE AEROSPACE
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indexes News
      • TSX COMP
      • TSX VENTURE
      • S&P 500
      • DOW JONES
      • NASDAQ 100
      • FTSE 100
      • CAC 40
      • DAX
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • CAD / USD
      • CAD / MXN
      • CAD / BRL
      • CAD / EUR
      • CAD / INR
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Nations
      • Emerging Countries
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • Macroeconomics
      • Policy
      • Geopolitics
      • Technology
      • International Trade
      • Military conflicts
      • Taxation
      • Sustainable development
      • Legal, Regulation, and Crime
    • Companies
      • Financial Results
      • Analyst Recommendations
      • Transcripts
      • Press releases
      • Insider transaction
      • Controversies
      • Innovations and expansions
      • IPOs
      • Rumors
      • Activism
      • Negative surprises
      • Positive surprises
      • New Contracts
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Economy
    • Sectors
    • All our articles
    • Most Read News
    • Hot News
  • Analysis
    • All Articles
    • Must Read
    • Equities Analysis
    • Interviews
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
    • Stock Trading Strategies
  • Calendar
    • Economic Calendar
    • Company calendar
  • Stock Picks
    • All our investments
    • United States
    • Europe
    • Asia, Pacific
  • Portfolios
    • USA Portfolio
    • European Portfolio
    • Asian Portfolio
    • Virtual Portfolios
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Low volatility
      • Top ROE
      • Yield stocks
      • Trend-Following Stocks
      • Multibaggers
      • Growth stocks
    • Investment Themes
      • Homepage
      • Place your bets
      • Semiconductors
      • 3D Printing
      • The Golden Age of Video Games
      • Pricing Power
      • uranium
  • Rankings
    • Top Movers
      • Short-Term Gainers & Losers
      • Long-term Gainers & Losers
      • Unusual volumes
      • New Historical Highs
      • New Historical Lows
    • Top Fundamentals
      • Fundamental Composite
      • Sales growth
      • Earnings Growth
      • Profitability
      • Finances
    • Rankings Valuation
      • Valuation Composite
      • Capitalization
      • P/E ratio
      • Enterprise value
      • Yield
      • Price to Book (PBR)
      • Free Cash Flow (FCF)
    • Top Consensus
      • Consensus composite
      • Analyst Opinion
      • Target price
      • Opinion Divergences
      • Estimates Revisions
      • Analyst coverage
    • Technical Analysis Rankings
      • RSI
      • GAPS
      • STIM
      • Daily Breakouts
      • Weekly Breakouts
      • Trends
      • Volatility
    • Top ranking ESG
      • ESG MSCI
      • Environment
      • Social
      • Governance
      • Islamic Finance
      • Paris Agreement
  • Screeners
    • Stock Screener Home
    • Investment Themes
      • Private Equity
      • Water
      • Hydrogen
      • Cybersecurity
      • Diabetes
      • Biomass
    • Technical Rankings
      • Oversold stocks
      • Overbought stocks
      • Close to resistance
      • Close to support
      • Accumulation Phases
      • Most volatile stocks
    • Fundamental Rankings
      • Top Investor Rating
      • Top Trading Rating
      • Top Consensus
      • Top Growth
      • Top Dividends
      • Low valuations
    • My Screeners
      • All my stocks
      • Watchlists
      • Virtual Portfolios
  • Tools
    • MarketScreener tools
      • Stock Screener
      • iPhone app
    • Expert tools
      • Stock Screener PRO
      • Portfolio Creator
      • Event Screener
    • Dynamic Chart
    • Company calendar
    • Economic Calendar
    • Currency Converter
  • Our Services
    • Our subscriptions
    • Our Stock Picks
    • Stock Screener
    • Thematic Investment Lists
    • MarketScreener Portfolios
      • European Portfolio
      • USA Portfolio
      • Asian Portfolio
Stock NOVN NOVARTIS AG
Add to a list

Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Real-time Estimate Cboe Europe
Other stock markets
08:37:11 2026-01-23 EST
5-day change 1st Jan Change
115.51 CHF +0.36% Intraday chart for Novartis AG -0.22% +5.24%
03:24am India's Cipla posts steeper-than-expected quarterly profit slump on tumour drug supply crunch RE
01-22 Europe's Key Companies – Telenor Jumps 8.1 Percent FW
Summary
Quotes
Charts
Technical Analysis Static Chart Total Return chart News Chart Sector Chart Comparison Chart Relative Strength Chart
News
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas
Company
Profile Governance Share ownership Group Connections
Financials
Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
Valuation
Valuation ratios Dividend
Consensus
Analysts' Opinion Estimates Revisions
Ratings
Calendar
Sector
Sector performance Sector valuations Sector dividends Financial comparisons Sector ratings Sector consensus Sector revisions
ETFs
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

US Court Rejects Novartis' Appeal to Block Heart Failure Drug's Generic Version

Published on 12/04/2024 at 11:48 pm EST - Modified on 12/04/2024 at 11:49 pm EST

MT Newswires
Share
LockThis article is reserved for members
Unlock the article: REGISTER NOW!
100% Free Registration
Already a customer? Log In
mtnewswires logo
© MT Newswires - 2024
Share

Latest news about Novartis AG

03:24am India's Cipla posts steeper-than-expected quarterly profit slump on tumour drug supply crunch RE
01-22 Europe's Key Companies – Telenor Jumps 8.1 Percent FW
01-21 Zura Bio Appoints Sandeep Kulkarni as CEO MT
01-21 Zura Bio Announces Chief Executive Officer Changes, Effective January 21, 2026 CI
01-21 NOVARTIS AG : Gets a Sell rating from Goldman Sachs ZD
01-20 Global drugmakers rush to boost US presence as tariff threat looms RE
01-20 Novartis Seen Largely Shielded From US Tariffs MT
01-20 Novartis expects to eliminate US tariff exposure by mid-2026, CEO tells CNBC RE
01-20 Novartis CEO Vas Narasimhan says we think we have an agreement with US government that shields us from tariffs - CNBC interview RE
01-20 GSK makes $2.2 billion swoop for RAPT Therapeutics' food allergy drug RE
01-20 Pfizer Limited Announces Senior Management Personnel Changes CI
01-19 Switzerland's Novartis Secures US FDA Breakthrough Designation for Sjögren's Candidate Ianalumab MT
01-18 Novartis Lands US FDA Breakthrough Therapy Classification for Ianalumab in Sjögren's Disease MT
01-16 Novartis Ianalumab Receives Fda Breakthrough Therapy Designation for Sjogren's Disease CI
01-16 Novartis Receives US FDA Breakthrough Therapy Designation for Ianalumab to Treat Sjogren's Disease MT
01-16 Novartis - Ianalumab receives FDA breakthrough therapy designation for Sjögren's disease RE
01-16 Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren's disease DJ
01-16 NOVARTIS AG : UBS sticks Neutral ZD
01-16 NOVARTIS AG : Deutsche Bank keeps its Buy rating ZD
01-15 Trump Launches Health Care Plan to Reduce Drug Costs MT
01-15 Pharma sector doubles down on AI amid hopes of slashing costs, timelines RE
01-15 NOVARTIS AG : Barclays remains Neutral ZD
01-14 Dr. Reddy's Laboratories Launches Olopatadine Hydrochloride Ophthalmic Solution in US MT
01-14 SciNeuro Grants Novartis Rights for Alzheimer's Disease Drug MT
01-14 Swiss stocks - Factors to watch on January 14 RE

Chart Novartis AG

Chart Novartis AG
NOVN: Dynamic Chart

Company Profile

Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (29.3%); - immunology (18.5%); - cardiovascular, renal and metabolic diseases (17%); - neuroscience (9.4%). The remaining net sales (25.8%) are from contract manufacturing of pharmaceutical products. At the end of 2024, Novartis AG had over 30 production sites worldwide. Net sales are distributed geographically as follows: Europe (30.9%), the United States (42%), Asia/Africa/Australasia (20%), Canada and Latin America (7.1%).
Employees
75,883
Sector
Pharmaceuticals
Calendar
02-03 - Q4 2025 Earnings Release
More about the company

Income Statement and Estimates

More financial data

Analysis / Opinion

Novartis target price raised after upgrades

Novartis target price raised after upgrades

December 05, 2025 at 11:23 am

Novartis CEO Says They Will Have to 'Tackle Rhetoric' in US Healthcare

January 21, 2025 at 05:56 am
Novartis CEO Says They Will Have to 'Tackle Rhetoric' in US Healthcare
More analyses

Ratings

Trader

Trader

This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Investor

Investor

This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Global

Global

This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quality

Quality

This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

ESG MSCI
AAA
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
145.62USD
Average target price
140.84USD
Spread / Average Target
-3.28%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
Indices Europe America Asia

 

 
 
 
My Watchlist
 

My lists
Rankings
 

More Rankings
Rankings
 

More Rankings

Currency / Forex

Currencies & Forex

Commodities

Commodities

Cryptocurrencies

Cryptocurrencies

Interest Rates

Interest Rates Area
  1. Stock Market
  2. Equities
  3. NOVN Stock
  4. News Novartis AG
  5. US Court Rejects Novartis' Appeal to Block Heart Failure Drug's Generic Version
Best financial portal

Best financial
portal

More than 20 yearsat your side

More than 20 years
at your side

Trustpilot
+ 1,300,000members

+ 1,300,000
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-12pm / 2pm-6pm GMT + 1

Contact us
MarketScreener, Stock Market Live
Legal information | Cookie settings | About us | Copyright © 2026 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
All transcripts on over 9000 companies, on the day they post their earnings!
Unlock them now!
Unlock them now!

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong